1. Home
  2. KEQU vs ZNTL Comparison

KEQU vs ZNTL Comparison

Compare KEQU & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$39.07

Market Cap

124.6M

Sector

Industrials

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$1.38

Market Cap

118.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
ZNTL
Founded
1906
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
118.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KEQU
ZNTL
Price
$39.07
$1.38
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$5.87
AVG Volume (30 Days)
9.3K
494.2K
Earning Date
12-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$26,865,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.59
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$1.01
52 Week High
$71.33
$3.53

Technical Indicators

Market Signals
Indicator
KEQU
ZNTL
Relative Strength Index (RSI) 47.32 46.77
Support Level $37.50 $1.34
Resistance Level $41.04 $1.48
Average True Range (ATR) 1.44 0.07
MACD 0.22 0.01
Stochastic Oscillator 51.45 41.18

Price Performance

Historical Comparison
KEQU
ZNTL

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: